UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000027275
Receipt number R000029304
Scientific Title Laparoscopic intraperitoneal observational study in patients undergoing open surgery for abdominal aortic and iliac aneurysms
Date of disclosure of the study information 2017/05/09
Last modified on 2024/04/01 15:54:24

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Laparoscopic intraperitoneal observational study in patients undergoing open surgery for abdominal aortic and iliac aneurysms

Acronym

Laparoscopic observation of abdominal aortic aneurysms

Scientific Title

Laparoscopic intraperitoneal observational study in patients undergoing open surgery for abdominal aortic and iliac aneurysms

Scientific Title:Acronym

Laparoscopic observation of abdominal aortic aneurysms

Region

Japan


Condition

Condition

Abdominal aortic aneurysm and/or iliac artery aneurysm

Classification by specialty

Vascular surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is investigate safety and efficacy of laparoscopic intraperitoneal observation in patients undergoing open surgery for abdominal aortic and iliac aneurysms. This is a pilot study to complete laparoscopic aortic surgery in the future.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase I,II


Assessment

Primary outcomes

Efficacy: ability to observe infrarenal aorta and common iliac artery using laparoscopy
It is assessed during surgery.

Key secondary outcomes

Safety: to assess damage of the abdominal viscera or other adverse events at the time of discharge


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment Maneuver

Interventions/Control_1

In patients who undergo open surgery for abdominal aortic and/or iliac aneurysms, intraperitoneal space, especially infrarenal aorta, is observed using a laparoscope under general anesthesia.
After laparoscopic observation, open surgery for abdominal aortic and/or iliac aneurysms will be done.
Study period is from the day of the surgery to the day of discharge.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients falling under all the following conditions are included of this study.
1) Patients who have abdominal aortic aneurysm (the maximum diameter is more than 4.5 cm) and/or iliac aneurysms (the maximum diameter is more than 3.0 cm) and are candidates for open surgery for the disease
2) Patients whose general condition is good and who have no serious comorbidities.
3) Patients who is more than 20 years of age
4) Patients who obtained document consent by his/her free will with sufficient understanding, after receiving sufficient explanation for the participation of this study
5) Patients in a hospital

Key exclusion criteria

Patients who fall under any of the following conditions are excluded of this study.

1) Patients who are candidates for endovascular aneurysm repair (EVAR)
2) Ruptured aneurysms
3) Emergency operation
4) Patients who are more than 80 years of age
5) Patients who have a history of myocardial infarction, unstable angina, serious hepatic disease (AST (GOT) > 100 U and/or ALT (GTP) > 100 U), serious kidney disease (serum creatinine > 2.0 mg/dL), or serious pulmonary disease (FEV1 < 1000 ml or FEV1% < 70%)
6) Female patients who are pregnant or have the potential to become pregnant
7) Lactating female patients
8) Patients who are judged as inappropriate for research by research responsibilities (sharing) doctors

Target sample size

5


Research contact person

Name of lead principal investigator

1st name TOSHIFUMI
Middle name
Last name KUDO

Organization

Tokyo Medical and Dental University

Division name

Vascular Surgery

Zip code

113-8519

Address

1-5-45, Yushima, Bunkyo-ku, Tokyo

TEL

03-5803-5255

Email

t-kudo.srg1@tmd.ac.jp


Public contact

Name of contact person

1st name TOSHIFUMI
Middle name
Last name KUDO

Organization

Tokyo Medical and Dental University

Division name

Vascular Surgery

Zip code

113-8519

Address

1-5-45, Yushima, Bunkyo-ku, Tokyo

TEL

03-5803-5255

Homepage URL


Email

t-kudo.srg1@tmd.ac.jp


Sponsor or person

Institute

Tokyo Medical and Dental University

Institute

Department

Personal name



Funding Source

Organization

Tokyo Medical and Dental University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

IRB of Tokyo Medical and Dental University

Address

1-5-45, Yusmiya, Bunkyo-ku, Tokyo

Tel

03-5803-5226

Email

syomu1.adm@tmd.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 05 Month 09 Day


Related information

URL releasing protocol

https://www.tmd.ac.jp/srg/synnryou/vascularsrg/134_5ab8397790df6/

Publication of results

Published


Result

URL related to results and publications

https://www.tmd.ac.jp/srg/synnryou/vascularsrg/134_5ab8397790df6/

Number of participants that the trial has enrolled

5

Results

Protocol was completed in 5 patients.

Results date posted

2024 Year 04 Month 01 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Age: 61-68
All male

Participant flow

Protocol was completed in 5 patients.

Adverse events

none

Outcome measures

Protocol was completed in 5 patients.
No adverse event was found in all cases.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 05 Month 09 Day

Date of IRB

2017 Year 06 Month 23 Day

Anticipated trial start date

2017 Year 06 Month 23 Day

Last follow-up date

2020 Year 03 Month 31 Day

Date of closure to data entry

2024 Year 03 Month 31 Day

Date trial data considered complete

2024 Year 03 Month 31 Day

Date analysis concluded

2024 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2017 Year 05 Month 09 Day

Last modified on

2024 Year 04 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029304